Collegium Pharmaceutical, Inc. COLL
Nov 12, 2026, 10:41 AM EST
- YTD
- -46.54%
- 1 year
- -47.73%
COLL free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
327,583,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 327,583,000 | 124,255,000 | 61.11% |
| FY 2024 | 2024-12-31 | 203,328,000 | -70,960,000 | -25.87% |
| FY 2023 | 2023-12-31 | 274,288,000 | 151,680,000 | 123.71% |
| FY 2022 | 2022-12-31 | 122,608,000 | 20,995,000 | 20.66% |
| FY 2021 | 2021-12-31 | 101,613,000 | 381,443,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -279,830,000 | -301,175,000 | -1410.99% |
| FY 2019 | 2019-12-31 | 21,345,000 | -123,691,000 | -85.28% |
| FY 2018 | 2018-12-31 | 145,036,000 | 213,044,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -68,008,000 | 7,522,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -75,530,000 | -53,601,000 | Not meaningful |
| FY 2015 | 2015-12-31 | -21,929,000 | -3,974,000 | Not meaningful |
| FY 2014 | 2014-12-31 | -17,955,000 | -1,219,000 | Not meaningful |
| FY 2013 | 2013-12-31 | -16,736,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-09T06:01:15.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.